Greenwich, CT, United States of America

Johanna Hansen

This inventor holds 8 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2020-2026.

USPTO Granted Patents = 8 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 3

Forward Citations = 64(Granted Patents)


Company Filing History:


Years Active: 2020-2026

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Johanna Hansen: Innovator in Antibody Development

Introduction

Johanna Hansen is a prominent inventor based in Greenwich, CT (US), known for her significant contributions to the field of biotechnology. With a total of five patents to her name, she has made remarkable strides in the development of antibodies aimed at combating viral infections.

Latest Patents

Among her latest patents is the development of Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments. This patent provides antibodies and antigen-binding fragments that specifically bind to a coronavirus spike protein. The methods outlined in this patent are designed for treating or preventing viral infections, particularly those caused by coronaviruses.

Career Highlights

Johanna Hansen is currently employed at Regeneron Pharmaceuticals, Inc., where she continues to innovate and contribute to the advancement of medical science. Her work focuses on the development of therapeutic solutions that address pressing health challenges.

Collaborations

Some of her notable coworkers include Robert Babb and Alina Baum, who collaborate with her on various projects within the company.

Conclusion

Johanna Hansen's work in antibody development is paving the way for new treatments against viral infections. Her innovative spirit and dedication to research exemplify the impact of inventors in the field of biotechnology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…